SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study
Andrew G. Letizia, Yongchao Ge, Sindhu Vangeti, Carl Goforth, Dawn L. Weir, Natalia A. Kuzmina, Corey A. Balinsky, Hua‐Wei Chen, Dan Ewing, Alessandra Soares‐Schanoski, Mary‐Catherine George, William D. Graham, Franca R. Jones, Preeti Bharaj, Rhonda A. Lizewski, Stephen E. Lizewski, Jan Marayag, Nada Marjanović, Clare Miller, Sagie Mofsowitz, Venugopalan D. Nair, Edgar Nunez, Danielle Parent, Chad K. Porter, Ernesto Santa Ana, Megan A. Schilling, Daniel Stadlbauer, Victor A. Sugiharto, Michael Termini, Peifang Sun, Russell P. Tracy, Florian Krammer, Alexander Bukreyev, Irene Ramos, Stuart C. Sealfon
Topics & Concepts
MedicineProspective cohort studySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Cohort studyCoronavirus disease 2019 (COVID-19)Cohort2019-20 coronavirus outbreakYoung adultVirologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies